NO145574C - Analogifremgangsmaate til fremstilling av 2,6-dimetyl-3-metoksykarbonyl-4-(2`-nitrofenyl)-1,4-dihydropyridin-5-karboksylsyreisobutylester - Google Patents

Analogifremgangsmaate til fremstilling av 2,6-dimetyl-3-metoksykarbonyl-4-(2`-nitrofenyl)-1,4-dihydropyridin-5-karboksylsyreisobutylester

Info

Publication number
NO145574C
NO145574C NO763608A NO763608A NO145574C NO 145574 C NO145574 C NO 145574C NO 763608 A NO763608 A NO 763608A NO 763608 A NO763608 A NO 763608A NO 145574 C NO145574 C NO 145574C
Authority
NO
Norway
Prior art keywords
dihydropyridine
methoxycarbonyl
nitrophenyl
dimethyl
preparation
Prior art date
Application number
NO763608A
Other languages
English (en)
Other versions
NO145574B (no
NO763608L (no
Inventor
Egbert Wehinger
Friedrich Bossert
Arend Heise
Stanislav Kazda
Kurt Stoepel
Wulf Vater
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO763608L publication Critical patent/NO763608L/no
Publication of NO145574B publication Critical patent/NO145574B/no
Publication of NO145574C publication Critical patent/NO145574C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO763608A 1975-11-05 1976-10-22 Analogifremgangsmaate til fremstilling av 2,6-dimetyl-3-metoksykarbonyl-4-(2`-nitrofenyl)-1,4-dihydropyridin-5-karboksylsyreisobutylester NO145574C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2549568A DE2549568C3 (de) 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
NO763608L NO763608L (no) 1977-05-06
NO145574B NO145574B (no) 1982-01-11
NO145574C true NO145574C (no) 1982-04-21

Family

ID=5960951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763608A NO145574C (no) 1975-11-05 1976-10-22 Analogifremgangsmaate til fremstilling av 2,6-dimetyl-3-metoksykarbonyl-4-(2`-nitrofenyl)-1,4-dihydropyridin-5-karboksylsyreisobutylester

Country Status (27)

Country Link
JP (1) JPS5259161A (no)
AT (1) AT352129B (no)
AU (1) AU498964B2 (no)
BE (1) BE847968A (no)
BG (6) BG25078A3 (no)
CA (1) CA1085406A (no)
CH (2) CH623038A5 (no)
CS (1) CS200499B2 (no)
DE (1) DE2549568C3 (no)
DK (1) DK146762C (no)
ES (2) ES452986A1 (no)
FI (1) FI60704C (no)
FR (1) FR2330395A1 (no)
GB (1) GB1516793A (no)
GR (1) GR61241B (no)
HK (1) HK12681A (no)
IE (1) IE43984B1 (no)
IL (1) IL50817A (no)
LU (2) LU76133A1 (no)
NL (2) NL175915C (no)
NO (1) NO145574C (no)
NZ (1) NZ182502A (no)
PL (2) PL105940B1 (no)
PT (1) PT65797B (no)
RO (1) RO70295A (no)
SE (1) SE423542B (no)
ZA (1) ZA766622B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE3212736A1 (de) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS5982192U (ja) * 1982-11-27 1984-06-02 エムケ−精工株式会社 扉
DE3312216A1 (de) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern
DE3312283A1 (de) * 1983-04-05 1984-10-18 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von unsymmetrischen 1,4-dihydropyridincarbonsaeureestern
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
DE2549568A1 (de) 1977-05-18
IE43984L (en) 1977-05-05
PT65797B (de) 1978-05-12
AU1935876A (en) 1978-05-11
BG24805A3 (en) 1978-05-12
DE2549568C3 (de) 1981-10-29
AT352129B (de) 1979-09-10
ATA814276A (de) 1979-02-15
HK12681A (en) 1981-04-10
FI60704C (fi) 1982-03-10
GB1516793A (en) 1978-07-05
SE7612308L (sv) 1977-05-06
NO145574B (no) 1982-01-11
DK146762B (da) 1983-12-27
BG24804A3 (en) 1978-05-12
FI60704B (fi) 1981-11-30
FI763160A (no) 1977-05-06
LU76133A1 (no) 1977-06-02
BE847968A (fr) 1977-05-04
SE423542B (sv) 1982-05-10
BG24668A3 (en) 1978-04-12
IL50817A (en) 1979-07-25
JPS5647185B2 (no) 1981-11-07
NL930035I1 (nl) 1993-08-02
PL106084B1 (pl) 1979-11-30
CH623038A5 (en) 1981-05-15
PT65797A (de) 1976-12-01
NO763608L (no) 1977-05-06
GR61241B (en) 1978-10-12
NL175915C (nl) 1985-01-16
FR2330395B1 (no) 1978-12-22
JPS5259161A (en) 1977-05-16
BG24803A3 (en) 1978-05-12
CA1085406A (en) 1980-09-09
ZA766622B (en) 1977-10-26
IE43984B1 (en) 1981-07-15
BG25078A3 (en) 1978-07-12
NZ182502A (en) 1978-07-28
CS200499B2 (en) 1980-09-15
IL50817A0 (en) 1977-01-31
PL105940B1 (pl) 1979-11-30
DE2549568B2 (de) 1980-08-21
BG25079A3 (en) 1978-07-12
ES452986A1 (es) 1977-12-16
DK146762C (da) 1984-06-12
NL7612198A (nl) 1977-05-09
AU498964B2 (en) 1979-03-29
FR2330395A1 (fr) 1977-06-03
DK498476A (da) 1977-05-06
NL930035I2 (nl) 1993-10-01
RO70295A (ro) 1981-08-17
ES463166A1 (es) 1978-07-16
LU88275I2 (no) 1994-02-03
CH622779A5 (en) 1981-04-30

Similar Documents

Publication Publication Date Title
SE426944B (sv) Forfarande for framstellning av alkylenkarbonater
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
DK146626C (da) Analogifremgangsmaade til fremstilling af 4'-deoxydaunomycin
SE429961B (sv) Forfarande for framstellning av mjolksyra
SE7603791L (sv) Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner
SE434951B (sv) Nytt forfarande for framstellning av 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
SE7613565L (sv) Forfarande for framstellning av fusidinsyraderivat
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE425783B (sv) Analogiforfarande for framstellning av lysergsyraamider
SE7803853L (sv) Forfarande for framstellning av estrar av oxalsyra
DK226476A (da) Fremgangsmade til fremstilling af propargyl-2-phenylamino-imidazoliner-(2) eller syreadditionssalte heraf
NO145574C (no) Analogifremgangsmaate til fremstilling av 2,6-dimetyl-3-metoksykarbonyl-4-(2`-nitrofenyl)-1,4-dihydropyridin-5-karboksylsyreisobutylester
SE426065B (sv) Forfarande for framstellning av nikotinsyraamid
SE7613839L (sv) Forfarande for framstellning av 2(1h)-kinazolinonderivat
SE440080B (sv) Forfarande for framstellning av klavulansyraderivat
SE423097B (sv) Analogiforfarande for framstellning av apovinkaminoestrar
NO152451C (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
DK142990C (da) Fremgangsmaade til fremstilling af antibakterielt virksomme aldehydderivater af clavulansyre
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
NO141716C (no) Fremgangsmaate for fremstilling av tiokarbaminsyreestere
DK143905C (da) Analogifremgangsmaade til fremstilling af fusidinsyrederivater
SE7614091L (sv) Forfarande for framstellning av tiadiazolylderivat av 7-acylamido-3-cefem-4-karbonsyra
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
NO142076C (no) Fremgangsmaate til fremstilling av perpropionsyreopploesninger
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror